Kalaris Therapeutics Stock (NASDAQ:KLRS)
Previous Close
$6.71
52W Range
$5.87 - $24.15
50D Avg
$8.66
200D Avg
$13.39
Market Cap
$129.05M
Avg Vol (3M)
$31.77K
Beta
-
Div Yield
-
KLRS Company Profile
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.